EquoPro® S-Equol Wins the 2025 Ringier Technology Innovation Award
SHANGHAI, China, 2025 — Shanghai EGT Synbio Group Co., Ltd. announced that its targeted women’s healthy-aging ingredient EquoPro® (S)-Equol has won the 2025 Food & Beverage Industry Ringier Technology Innovation Award in the Functional Ingredients / Innovative Raw Materials category.
Organized by Ringier Trade Media, the Ringier Technology Innovation Awards are widely recognized in China’s industrial and manufacturing sectors for honoring technologies, products, and solutions with outstanding innovation value and market application potential.
Among more than 80 advanced products and technologies, EquoPro® stood out for its targeted application in women’s health, its synthetic biology-based manufacturing pathway, and its potential to support the next generation of precision nutrition products.
This recognition not only reflects Shanghai EGT Synbio Group’s research capability in synthetic biology, but also marks another step forward for China’s bio-manufacturing industry in the high-value functional ingredient sector.
The Ringier Technology Innovation Award recognizes technologies and products that demonstrate meaningful contribution to industry development, strong innovation value, and clear commercialization potential.
EquoPro® (S)-Equol was recognized in the Functional Ingredients / Innovative Raw Materials category for addressing a growing market need: science-based, targeted nutritional solutions for women aged 35 and above.
As global consumers pay increasing attention to healthy aging, menopause wellness, bone health, skin condition, emotional well-being, and long-term vitality, women’s health is becoming one of the most important growth areas in functional foods, dietary supplements, and precision nutrition.
EquoPro® is positioned as a next-generation ingredient designed to support this shift.
Q: What does the Ringier Technology Innovation Award recognize?
A: It recognizes innovative technologies and products with strong industry value, technical differentiation, and market application potential.
Q: Why was EquoPro® recognized?
A: EquoPro® was recognized for its targeted positioning in women’s healthy aging, its scalable synthetic biology-based production, and its potential to support differentiated functional nutrition products.
Q: What does this mean for brand owners?
A: For brands, the award provides an additional layer of industry credibility and supports EquoPro® as a differentiated ingredient for premium women’s health and healthy-aging formulations.
With the acceleration of global population aging, healthy aging and precision nutrition are becoming major drivers of the functional food and dietary supplement markets.
Within this broader trend, women’s health needs around the age of 35 and beyond are attracting particular attention. Many women begin to experience changes related to hormonal fluctuation, skin aging, bone metabolism, sleep quality, emotional balance, and overall vitality.
EquoPro® (S)-Equol was developed by Shanghai EGT Synbio Group as a targeted functional ingredient for women’s healthy-aging applications.
Equol is an active metabolite of soy isoflavones. In the human body, only part of the population can naturally convert soy isoflavones into equol through specific gut microbiota. This creates significant variability in the performance of traditional soy isoflavone-based products.
EquoPro® provides the specific S-form of equol, supporting a more direct and standardized ingredient approach for women’s health product development.
Q: Why is the 35+ female consumer group important?
A: This group often begins to pay closer attention to early healthy-aging concerns, including skin condition, metabolic balance, bone health, sleep, mood, and long-term wellness management.
Q: What is S-equol?
A: S-equol is a biologically relevant metabolite associated with soy isoflavone metabolism. It has attracted attention in women’s health research due to its structural similarity to estrogen and its potential role in menopause-related wellness support.
Q: Why is direct S-equol delivery different from soy isoflavones?
A: Traditional soy isoflavones depend on individual gut microbiota conversion. Since not everyone can efficiently produce equol, direct S-equol delivery helps reduce variability and supports more precise formulation design.
EquoPro® is designed to support the development of women’s healthy-aging products across multiple wellness dimensions.
In women’s health research and product development, S-equol is often discussed in relation to menopause wellness, bone health, cardiovascular wellness, skin condition, and healthy-aging nutrition. Its molecular structure is similar to estrogen, and it has been studied for selective interaction with estrogen receptor pathways.
For brands, this creates an opportunity to move beyond generic “women’s supplement” concepts and develop more targeted, science-based product narratives.
Potential application directions include:
- Menopause-support dietary supplements
- Women’s healthy-aging formulas
- Bone health and vitality products
- Beauty-from-within products
- Functional foods for women 35+
- Premium nutraceutical products
- Personalized nutrition solutions
Q: Can EquoPro® be used for menopause-support products?
A: EquoPro® can be positioned as an ingredient for menopause wellness and women’s healthy-aging formulations, subject to local regulatory requirements and finished-product claim review.
Q: Why is EquoPro® relevant to bone health and metabolic wellness?
A: Hormonal changes during aging are often associated with changes in bone metabolism and overall wellness. S-equol has been studied in relation to women’s health and may support product concepts in these areas.
Q: Can EquoPro® be used in oral beauty products?
A: Yes. It may be considered for beauty-from-within and skin healthy-aging concepts, especially when combined with other ingredients such as collagen peptides, hyaluronic acid, antioxidants, ceramides, or ergothioneine.
Shanghai EGT Synbio Group Co., Ltd. is a high-tech biotechnology company focused on synthetic biology, biotransformation processes, and the R&D and production of natural healthy-aging active ingredients.
The company has built a portfolio of core ingredients including Dr.Ergo® L-Ergothioneine, EquoPro® (S)-Equol, Dr.SPD® Spermidine, and HariCera™ Elastic Ceramide. Its products are designed for dietary supplements, functional nutrition, oral beauty, healthy aging, and performance personal care applications, serving leading health food, functional dietary, and beauty brands worldwide.
Email: sales@ygingredients.com
Tel: +86 13816952472
Follow our WeChat official account for more information!
